← Eichor
Study identifier: NCT04306432 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

Cognitive Function After Radiation Therapy for Primary Brain Tumours

Condition: Primary Brain Tumour · Radiation Toxicity · Cognitive Impairment  ·  Sponsor: University of Aarhus

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersYes

About this study

This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.

This description comes directly from the study's public registry record.

Talk to the study team

Morten Høyer, MD  ·  +45 2328 2823  ·  morthoey@rm.dk

Lene Haldbo-Classen, MD  ·  +4523342761  ·  lenhaldb@rm.dk

Always discuss trial participation with your own doctor first.

Locations (5)

Department of Oncology, RigshospitaletCopenhagen, Capital Region, DenmarkRecruiting
Danish Center for Particel TherapyAarhus, Region Midt, DenmarkRecruiting
Department of Oncology, Aarhus University HospitalAarhus, Region Midt, DenmarkRecruiting
Department of Oncology, Aalborg University HospitalAalborg, Region Nord, DenmarkRecruiting
Department of Oncology, Odense University HospitalOdense, Region Syd, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04306432